Browse > Article
http://dx.doi.org/10.22246/jikm.2018.39.6.1181

The Effect of Alisma canaliculatum and Polyporus umbellatus Extracts on Adipogenic Differentiation of Human Bone Marrow Derived Mesenchymal Stromal Stem cells  

Yu, Sung-ryul (Dept. of Clinical Laboratory Science, Se-Myung University)
Kim, Si-hyun (Dept. of Clinical Laboratory Science, Se-Myung University)
Shin, Seon-mi (Dept. of Internal Medicine, College of Oriental Medicine, Se-Myung University)
Publication Information
The Journal of Internal Korean Medicine / v.39, no.6, 2018 , pp. 1181-1190 More about this Journal
Abstract
Objective: This study investigated the effect of purified medical herb extracts such as Alisma canaliculatum and Polyporus umbellatuson adipogenic differentiation of human bone marrow derived mesenchymal stromal stem cells (hBMSCs). Methods: Two different medical herb were extracted using hot distilled water. The optimal concentration of extracts were fixed at 100 ng/ml by means of cell viability and cytotoxic assay. To test the adipogenic differentiation ability of extracts, we induced the adipogenesis of hBMSCs for 21 days. At day 5, the cell was harvested to check mRNA and protein expression level of adipogenic related factors. The efficacy of lipid droplet formation was evaluated using the oil-red O staining method at days 21. Results: Two different medical herb extracts have no toxicity on hBMSCs. And two different medical herb extracts significantly decreased formation of lipid droplet compared with control groups in hBMSCs. The A. canaliculatum extract group showed the lowest mRNA and protein expression level of adipossgenic related transcription factors. This data suggests that extract of A. canaliculatum and P. umbellata decrease the adipogenic differentiation of hBMSCs. Conclusions: Our findings indicate that water-extract of A. canaliculatum and P. umbellata will be useful therapeutic reagents for prevention of obesity related disease such as diabetes, hyperlipidemia, coronary artery disease, and osteoporosis.
Keywords
hBMSCs; Adipogenic differentiation; Alisma canaliculatum; Polyporus umbellata;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Martin DR. Cox NR. Hathcock TL. Niemeyer GP. Baker HJ. Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 2001;30(8):879-86.   DOI
2 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7.   DOI
3 Jung HS, Lee YJ, Kim YH, Paik SI, Kim JW, Lee JW. Peroxisome proliferator-activated receptor gamma/singal transducers and activators of transcription 5a pathway plays a key factor in adipogenesis of human bone marrow-derived stromal cells and 3T3-L1 preadipocytes. Stem Cells Dev 2012;21(3):465-75.   DOI
4 Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008;20(4):429-34.   DOI
5 Moerman EJ, Teng K, Lipschitz DA, Lecka-Czernik B. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell 2004;3(6):379-89.   DOI
6 Yeung DK, Griffith JF, Antonio GE, Lee FK, Woo J, Leung PC. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study. J Magn Reson Imaging 2005;22(2):279-85.   DOI
7 Ferrari S, Reginster JY, Brandi ML, Kanis JA, Devogelaer JP, Kaufman JM, et al. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture. Arch Osteoporos 2016;11(1):37-48.   DOI
8 Pei L. Tontonoz P. Fat's loss is bone's gain. J Clin Invest2004;113(6):805-6.   DOI
9 Magaziner J, Simonsick EM, Kashner TM, Hebel JR, Kenzora JE. Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study. J Gerontol 1990;45:M101-M7.   DOI
10 Kawai M. Devlin MJ. Rosen CJ. Fat targets for skeletal health. Nat Rev Rheumatol 2009;5(7):365-72.   DOI
11 World Health Organization (WHO). Obesity and overweight in Media centre. 2011.
12 Diel I, Bergner R, Grotz K. Adverse effects of bisphosphonates: current issues. J Support Oncol 2007;5(10):475-82.
13 Pourali P, Yahyaei B. (2018). Wound healing property of a gel prepared by the combination of Pseudomonas aeruginosa alginate and Alhagi maurorum aqueous extract in rats. Dermatol Ther 2018:e12779.
14 Yu SR, Shin SM. Effects of Carthamus Tinctorius Extract on Adipogenic Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stromal Stem Cells. Korean J Orient Int Med 2017;38(1):1-9.
15 Yu SR. The Effect of Medical Herb Extract on Osteogenic Differentiation in MC3T3-E1 Cells. 한국보건기초의학회지 2015;9(1):17-22.
16 McClung M, Harris S, Miller P, Bauer D, Davison K, Dian L, et al. Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 2013;126(1):13-20.   DOI
17 Chung HJ, Kim WK, Oh J, Kim MR, Shin JS, Lee J, et al. Anti-Osteoporotic Activity of Harpagoside by Upregulation of the BMP2 and Wnt Signaling Pathways in Osteoblasts and Suppression of Differentiation in Osteoclasts. J Nat Prod2017;24(80):434-42.
18 Seo BI, Jeong GY. The easily understanding herbology. Kyungsan: publishing department of Daegu Haany university; 2012, p. 185-6.
19 Lu W, Adachi I, Kano K, Yasuta A, Toriizuka K, Ueno M, et al. Pletelet aggregation potentiators from cho-rei. Chem Pharm Bull 1985;33(11):5083-7.   DOI
20 Jeong HS. Efficacy of Alismatis Orientale Rhizoma on Obesity induced by High Fat Diet. Kor J Herbology2013;28(3):95-106.   DOI
21 Zhang Y, Liu Y, Yan SC. Effect of Polyporus umbellatus polysaccahride on function of macrophages in the peritoneal cavities of mice with lesions. Cheih Ho Tsa Chih 1991;11(4):225-6.
22 Sato K, Osawa M, Suzuki Y, Oikawa S. Difference in fruiting capability of stocks in Grifola Frondosa and its allied species. Trans Mycol Soc Japan 1984;25:205-9.
23 Miyazaki T, Oikawa N, Yadomae T, Yamada H, Yamada Y. Relationship between the chemical structure and antitumor activity of glucans prepared from Grifolla umbellata. Carbohydrate Research1979;69(1):165-70.   DOI
24 Ueno Y, Okamoto Y, Yamauchi R, Kato K. An antitumor activity of the alkali-soluble polysaccharide (and its derivatives) obtained from the sclerotia of Grifora umbellata. Carbohydrate Research1982;101(1):160-7.   DOI
25 May L, Yun SC. Therapeutic investigation of Polyporusumbellatus polysaccahride on the children with pure immunity. J Traditional Chinese Medicine (China1)990;3:168-9.
26 Chang YF, Liu YY, Yun SC. Effect of Polyporus umbellatus polysaccahrides on macrophages of liver damaged mice. Intergrated J Chinese and Western Medicine (China1)991;11:225-6.
27 Xiong LL. Therapeutic effect of combined therapy of Salvia miltiorrhizae and Polyporus umbellatus polysaccharide in the treatment of chronic hepatitis B. Cheih Ho Tsa Chih 1993;13(9):516-7.
28 You JS, Hau DM, Chen KT, Huang HF. Combined effects fo chulling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer. Am J Chin Med 1994;22(1):19-28.   DOI
29 Ishida H. Studies of active substances in herbs used for hair treatment IV. The structure of the hair growth substance, polypurusterone A from Polyporus umbellatus fries. Chemical & Pharmaceutical Bulletin1999;47(11):1626-8.   DOI
30 Ishida H, Inaoka Y, Shibatani J, Fukushima M, Tsuji K. Studies of the active substances in herbs used for hair treatment II Isolation of hair regrowth substances acerosyringone and polyporusterone A and B from Polyporus umbellatus fries. Biol Pharm Bull 1999;22(1):1189-92.   DOI
31 Park JB, Lee HS, Hwang SY, Hong SB, Kim HD, Yun CY. Effect of combined plant extracts on anti-obesity in rats fed a high-fat diet. Kor J Aesthet Cosmetol2011;9(1):25-34.
32 Kwon HJ, Park YG. Statistical trends in family medicine journals. Korean J Fam Med 2012;33(1):9-16.   DOI
33 Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;369(9555):71-7.   DOI
34 Al-Tahami BA, Al-Safi Ismail AA, Sanip Z, Yusoff Z, Shihabudin TMT, Singh TSP, et al. Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects. J Nippon Med Sch 2017;84(3):125-32.   DOI
35 LaFleur J, McAdam-Marx C, Kirkness C, Brixner DI. Clinical risk factors for fracture in postmenopausal osteoporotic women: A review of the recent literature. Ann Pharmacother 2008;42(3):375-86.   DOI
36 Cao JJ. Effects of obesity on bone metabolism. J Orthop Surg Res 2011;6:30.   DOI
37 Chen JS, Sambrook PN. Antiresorptive therapies for osteoporosis: a clinical overview. Nat Rev Endocrinol2011;8(2):81-91.   DOI
38 Kaminage T, Yasukawa K, Kanno H, Tai T, Nunoura Y, Takido M. Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology 1996;53(5):382-5.   DOI
39 Stepan JJ, Alenfeld F, Boivin G, Feyen JH, Lakatos P. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. Endocr Regul 2003;37(4):225-38.
40 Wu JN. An illustrated Chinese materia medica. New York: Oxford University Press; 2005, p. 59, 111, 225, 235, 403, 565.